Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease
Dana J. Lukin, Anand Kumar, Kaveh Hajifathalian, Reem Z. Sharaiha, Ellen Scherl, Randy Longman, Gabriela Funez-dePagnier, Lucia Duenas-Bianchi, Vinita Jacob, Robert Battat, Tibor I. Krisko, Brett E. Fortune
Topics & Concepts
Inflammatory bowel diseaseMedicineCoronavirus disease 2019 (COVID-19)DiseaseInternal medicineBaseline (sea)GastroenterologyInfectious disease (medical specialty)OceanographyGeologyInflammatory Bowel DiseaseCOVID-19 and healthcare impactsCOVID-19 Clinical Research Studies